Thomas R Cox Selected Research

Carcinoma (Carcinomatosis)

10/2021	Pirfenidone Reduces Epithelial-Mesenchymal Transition and Spheroid Formation in Breast Carcinoma through Targeting Cancer-Associated Fibroblasts (CAFs).
1/2018	Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas R Cox Research Topics

Disease

31	Neoplasms (Cancer) 01/2021 - 01/2009
16	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2011
9	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2017
5	Fibrosis (Cirrhosis) 01/2021 - 03/2013
4	Colorectal Neoplasms (Colorectal Cancer) 11/2013 - 08/2008
3	Hypoxia (Hypoxemia) 01/2018 - 01/2009
2	Carcinoma (Carcinomatosis) 10/2021 - 01/2018
2	Disease Progression 01/2021 - 01/2017
2	Carcinogenesis 05/2019 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 03/2015
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Triple Negative Breast Neoplasms 10/2020
1	Adenocarcinoma of Lung 05/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2019
1	Retinoblastoma (Glioblastoma, Retinal) 12/2018
1	Adenocarcinoma 12/2018
1	Melanoma (Melanoma, Malignant) 09/2017
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Rectal Neoplasms (Rectal Cancer) 09/2017
1	Ovarian Neoplasms (Ovarian Cancer) 09/2015
1	Sarcoma (Soft Tissue Sarcoma) 03/2011

Drug/Important Bio-Agent (IBA)

15	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2021 - 01/2009
8	CollagenIBA 12/2019 - 01/2009
8	EnzymesIBA 01/2019 - 03/2011
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 10/2021 - 07/2012
2	perlecanIBA 12/2019 - 01/2019
2	IntegrinsIBA 05/2019 - 07/2018
2	Phosphotransferases (Kinase)IBA 01/2018 - 09/2015
2	Biomarkers (Surrogate Marker)IBA 09/2017 - 08/2008
1	pirfenidoneIBA 10/2021
1	CytokinesIBA 10/2021
1	Neurofibromin 2 (Merlin)IBA 10/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Collagen ReceptorsIBA 05/2019
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	AntibodiesIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	pertuzumabIBA 01/2019
1	Cyclin-Dependent Kinase 4IBA 12/2018
1	Retinoblastoma ProteinIBA 12/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Diphosphonates (Bisphosphonates)IBA 01/2018
1	LigandsIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	Fibrillar CollagensIBA 01/2018
1	Drug CombinationsIBA 09/2017
1	Protein Isoforms (Isoforms)IBA 09/2017
1	Oxidoreductases (Dehydrogenase)IBA 04/2017
1	AminesIBA 04/2017
1	HydrogelsIBA 01/2017
1	rho-Associated KinasesIBA 01/2017
1	Albumin-Bound Paclitaxel FDA Link 01/2017
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 01/2017
1	fasudil (AT 877)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	Estrogen ReceptorsIBA 01/2016
1	Myosin Type IIIBA 10/2015
1	PeriostinIBA 10/2015
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2015
1	Threonine (L-Threonine)FDA Link 09/2015
1	ProteomeIBA 09/2015
1	Phenobarbital (Luminal)FDA Link 03/2015
1	Endo180IBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 03/2011
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2009
1	Lamin Type A (Lamin A)IBA 08/2008
1	LaminsIBA 08/2008

Therapy/Procedure

18	Therapeutics 01/2021 - 03/2011
4	Drug Therapy (Chemotherapy) 12/2019 - 01/2017
1	Lab-On-A-Chip Devices 10/2021
1	Precision Medicine 10/2021